Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
ISRG - Intuitive Surgical, Inc.
Market Cap 110.28B P/E 78.66 EPS this Y 16.50% Ern Qtrly Grth 25.20%
Income 2.09B Forward P/E 48.21 EPS next Y 15.30% 50D Avg Chg -4.00%
Sales 7.57B PEG 5.18 EPS past 5Y 12.37% 200D Avg Chg 14.00%
Dividend N/A Price/Book 9.28 EPS next 5Y 14.08% 52W High Chg -12.00%
Recommedations 2.00 Quick Ratio 4.03 Shares Outstanding 355.35M 52W Low Chg 74.00%
Insider Own 0.52% ROA 7.99% Shares Float 353.23M Beta 1.40
Inst Own 90.59% ROE 15.77% Shares Shorted/Prior 3.97M/3.74M Price 313.87
Gross Margin 66.86% Profit Margin 27.65% Avg. Volume 1,687,895 Target Price 493.23
Oper. Margin 28.23% Earnings Date Oct 17 Volume 1,886,343 Change -3.11%
Healthcare | Medical Instruments & Supplies | United States
About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Intuitive Surgical, Inc. News
12/19/24 Intuitive Surgical, Inc. (ISRG) Declines More Than Market: Some Information for Investors
12/19/24 Intuitive Surgical price target raised to $640 from $570 at Truist
12/17/24 Palantir’s high valuation paints a stark picture of the S&P 500’s priciest picks
12/17/24 Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know
12/17/24 Prediction: 2 Stocks That'll Be Worth More Than Palantir 5 Years From Now
12/13/24 Intuitive Surgical, Inc. (ISRG) Stock Moves -0.94%: What You Should Know
12/10/24 Intuitive’s da Vinci beats non-robotic surgeries in cancer meta-analysis
12/09/24 Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock?
12/06/24 Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
12/06/24 ISRG Stock Reaches All-Time High: Strength in Uptrend to Continue?
12/05/24 Meta-analysis published in Annals of Surgery shows benefits of da Vinci surgery across seven oncologic procedures compared to laparoscopic and open
12/04/24 Intuitive Surgical, Inc. (ISRG) Beats Stock Market Upswing: What Investors Need to Know
12/03/24 Intuitive Surgical, Inc. (ISRG): A Bull Case Theory
12/03/24 These are the sectors investors need to watch
12/03/24 Intuitive Surgical (ISRG) Upgraded to Buy: Here's What You Should Know
12/03/24 How CMR Surgical is taking on robotics’ ‘800-pound gorilla’
12/02/24 Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
11/28/24 2 Excellent Healthcare Stocks to Hold Through the Next Decade
11/26/24 Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now
11/25/24 Wall Street Bulls Look Optimistic About Intuitive Surgical (ISRG): Should You Buy?
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Curet Myriam EVP & Chief Medical.. EVP & Chief Medical Officer Jan 26 Sell 370.15 4,318 1,598,308 189 01/29/24
Curet Myriam EVP & Chief Medical.. EVP & Chief Medical Officer Jan 26 Option 180.41 4,318 779,010 1,689 01/29/24
LEVY ALAN J Director Director Jan 26 Sell 370.2 2,000 740,400 25,319 01/29/24
LEVY ALAN J Director Director Jan 26 Option 122.37 2,000 244,740 27,247 01/29/24
Johnson Amal M Director Director Jan 26 Sell 370.08 6,696 2,478,056 11,706 01/29/24
Johnson Amal M Director Director Jan 26 Option 56.97 6,696 381,471 18,402 01/29/24
DeSantis Robert EVP & Chief Strategy.. EVP & Chief Strategy & Corp Op Nov 14 Sell 290 867 251,430 7,259 11/15/23
DeSantis Robert EVP & Chief Strategy.. EVP & Chief Strategy & Corp Op Nov 14 Option 243.97 867 211,522 7,529 11/15/23
LEVY ALAN J Director Director Nov 14 Sell 290 2,000 580,000 25,319 11/15/23
LEVY ALAN J Director Director Nov 14 Option 90.49 2,000 180,980 27,319 11/15/23
GUTHART GARY S CEO CEO Oct 24 Sell 267.99 32,345 8,668,137 29,840 10/26/23
GUTHART GARY S CEO CEO Oct 24 Option 49.34 33,750 1,665,225 50,936 10/26/23
DeSantis Robert EVP & Chief Strategy.. EVP & Chief Strategy & Corp Op Oct 24 Sell 272.95 1,110 302,974 7,259 10/25/23
DeSantis Robert EVP & Chief Strategy.. EVP & Chief Strategy & Corp Op Oct 24 Option 188.86 1,110 209,635 7,823 10/25/23
Ladd Amy L Director Director Sep 14 Sell 305.68 500 152,840 702 09/15/23
LEVY ALAN J Director Director Aug 07 Sell 310 2,000 620,000 25,319 08/08/23
LEVY ALAN J Director Director Aug 07 Option 80.91 2,000 161,820 25,784 08/08/23
DeSantis Robert EVP & Chief Strategy.. EVP & Chief Strategy & Corp Op Jul 25 Sell 323.13 2,535 819,135 7,259 07/26/23
DeSantis Robert EVP & Chief Strategy.. EVP & Chief Strategy & Corp Op Jul 25 Option 224.14 2,535 568,195 7,823 07/26/23
MOHR MARSHALL Executive VP Global.. Executive VP Global Business S Jun 14 Sell 325 11,250 3,656,250 24,136 06/15/23
MOHR MARSHALL Executive VP Global.. Executive VP Global Business S Jun 14 Option 59.46 11,250 668,925 35,386 06/15/23
BARRATT CRAIG H Director Director Jun 14 Sell 322.78 1,567 505,796 06/15/23
BARRATT CRAIG H Director Director Jun 14 Option 41.26 1,567 64,654 1,567 06/15/23
DeSantis Robert EVP & Chief Product.. EVP & Chief Product Officer Jun 14 Sell 325 2,443 793,975 7,259 06/15/23
DeSantis Robert EVP & Chief Product.. EVP & Chief Product Officer Jun 14 Option 290.33 2,443 709,276 9,702 06/15/23
BARRATT CRAIG H Director Director May 01 Sell 306 2,000 612,000 05/02/23
BARRATT CRAIG H Director Director May 01 Option 41.26 2,000 82,520 2,000 05/02/23
RUBASH MARK J Director Director Apr 28 Sell 300 7,323 2,196,900 15,482 05/01/23
RUBASH MARK J Director Director Apr 28 Option 169.93 7,323 1,244,397 16,005 05/01/23
RUBASH MARK J Director Director Apr 27 Option 0.0 482 15,482 04/28/23
Reed Monica P Director Director Apr 27 Option 0.0 482 1,037 04/28/23
NACHTSHEIM JAMI K Director Director Apr 27 Option 0.0 482 5,063 04/28/23
Ladd Amy L Director Director Apr 27 Option 0.0 482 1,202 04/28/23
LEVY ALAN J Director Director Apr 27 Option 0.0 482 25,319 04/28/23
Leonard Keith R Director Director Apr 27 Option 0.0 482 3,584 04/28/23
Beery Joseph C Director Director Apr 27 Option 0.0 482 1,802 04/28/23
BARRATT CRAIG H Director Director Apr 27 Option 0.0 655 25,351 04/28/23
KANIA DON R Director Director Apr 27 Option 0.0 482 3,269 04/28/23
Johnson Amal M Director Director Apr 27 Option 0.0 482 11,706 04/28/23
Rosa David J. EVP Chief Strategy &.. EVP Chief Strategy & Growth Of Apr 21 Sell 298.56 81,564 24,351,748 155,712 04/24/23
Rosa David J. EVP Chief Strategy &.. EVP Chief Strategy & Growth Of Apr 21 Option 42.64 108,000 4,605,120 196,476 04/24/23
RUBASH MARK J Director Director Apr 21 Option 150.87 8,135 1,227,327 15,927 04/24/23
RUBASH MARK J Director Director Apr 21 Sell 297.93 8,135 2,423,661 15,000 04/24/23
Widman Fredrik VP Corporate Control.. VP Corporate Controller Apr 21 Sell 297.87 630 187,658 2,233 04/24/23
DeSantis Robert EVP & Chief Product.. EVP & Chief Product Officer Apr 21 Sell 297.94 8,623 2,569,137 7,065 04/24/23
DeSantis Robert EVP & Chief Product.. EVP & Chief Product Officer Apr 21 Option 210.9 6,260 1,320,234 11,872 04/24/23
BARRATT CRAIG H Director Director Apr 21 Sell 297.92 6,000 1,787,520 04/24/23
BARRATT CRAIG H Director Director Apr 21 Option 41.26 6,000 247,560 2,000 04/24/23
Curet Myriam EVP & Chief Medical.. EVP & Chief Medical Officer Apr 21 Sell 299.48 9,623 2,881,896 327 04/24/23
Curet Myriam EVP & Chief Medical.. EVP & Chief Medical Officer Apr 21 Option 170.44 8,000 1,363,520 7,950 04/24/23